AxoGen, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue61.5M59.9M60.1M56.7M48.6M49.4M48.6M47.9M
Cost of Goods Sold15.3M15.5M14.1M14.6M13.6M11.8M12.2M12.6M
Gross Profit46.2M44.4M46.0M42.0M34.9M37.6M36.4M35.3M
R&D Expenses7.5M12.4M7.6M6.9M6.1M6.7M7.0M6.7M
Operating Expenses49.0M54.2M44.1M40.3M36.6M35.6M36.8M35.8M
Operating Income-2.8M-9.8M1.9M1.7M-1.7M2.0M-316K-428K
Other Income / Gains-16.8M-3.4M-1.2M-1.1M-2.2M-1.6M-1.5M-1.5M
Net Income-19.6M-13.2M708K579K-3.8M450K-1.9M-1.9M
EPS (Diluted)-0.38-0.280.0150.013-0.0850.01-0.042-0.044
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7520.7410.7660.7420.7190.7610.7490.738
General And Administrative Expenses12.9M14.6M10.8M9.7M9.5M8.8M10.8M9.4M
Selling And Marketing Expenses28.6M27.2M25.7M23.8M21.0M20.0M18.9M19.7M
Selling General And Administrative Expenses41.5M41.8M36.5M33.5M30.5M28.9M29.8M29.1M
Other Expenses00000-27K00
Cost And Expenses64.3M69.7M58.2M55.0M50.2M47.4M49.0M48.3M
Interest Income00225K225K0000
Interest Expense694K1.7M10.2M2.0M2.3M1.8M1.9M2.2M
Depreciation And Amortization02.9M1.7M1.8M1.9M1.9M2.0M2.1M
Ebitda-18.9M-8.5M12.6M4.4M298K4.2M2.0M2.3M
Ebitdaratio-0.307-0.1420.2110.0770.0060.0840.0410.049
Operating Income Ratio-0.046-0.1630.0320.03-0.0340.041-0.006-0.009
Income Before Tax-19.6M-13.2M708K579K-3.8M450K-1.9M-1.9M
Income Before Tax Ratio-0.319-0.220.0120.01-0.0790.009-0.038-0.04
Income Tax Expense00000000
Net Income Ratio-0.319-0.220.0120.01-0.0790.009-0.038-0.04
Epsdiluted-0.38-0.280.0140.012-0.0850.009-0.042-0.044
Weighted Average Shs Out51.6M46.9M45.9M45.6M45.2M44.9M43.9M43.7M
Weighted Average Shs Out Dil51.6M46.9M45.9M45.6M45.2M48.1M43.9M43.7M